Thanks Daniel. Under the Melanoma 'family' patents, it says the provisional patents cover "multiple uses of bisantrene in combination with other drugs". Yesterday's news foreshadowed that Zantrene may provide an effective single agent treatment for some Melanomas - would this use case be covered under any of our patents?
- Forums
- General
- General Comments / Chat
Thanks Daniel. Under the Melanoma 'family' patents, it says the...
-
- There are more pages in this discussion • 6,876 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.70 |
Change
-0.140(7.61%) |
Mkt cap ! $289.4M |
Open | High | Low | Value | Volume |
$1.88 | $1.89 | $1.70 | $456.4K | 259.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.70 | 8662 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.690 |
2 | 6661 | 1.685 |
1 | 727 | 1.680 |
1 | 5970 | 1.675 |
1 | 727 | 1.670 |
Price($) | Vol. | No. |
---|---|---|
1.700 | 8662 | 1 |
1.730 | 943 | 1 |
1.740 | 500 | 1 |
1.745 | 727 | 1 |
1.755 | 727 | 1 |
Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |